Caligan Partners »

Sagimet Biosciences Inc-a shares owned by Caligan Partners

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Caligan Partners from 13F filings

Historical chart of Caligan Partners investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Caligan Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Caligan Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $19M 2.5M 7.73

More positions owned by Caligan Partners

Liquidia Corporation Com New (LQDA)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)
Vaxcyte (PCVX)
Exelixis (EXEL)
Tango Therapeutics (TNGX)
Avalo Therapeutics Com New (AVTX)
Xenon Pharmaceuticals (XENE)
Adma Biologics (ADMA)
Lb Pharmaceuticals Com Shs (LBRX)
Immunocore Hldgs Ads (IMCR)
Miragen Therapeutics (VRDN)
Vor Biopharma Com New (VOR)
Sab Biotherapeutics Com New (SABS)
Inventiva Sa Ads (IVA)

View all positions for Caligan Partners

Top funds holding Sagimet Biosciences Inc-a

BlackRock
Balyasny Asset Management
Woodline Partners
Silverarc Capital Management
Vanguard Capital Management
BVF
Caligan Partners
Affinity Asset Advisors
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
Geode Capital Management
Blue Owl Capital Holdings
Baker Bros. Advisors
Millennium Management

View all funds holding Sagimet Biosciences Inc-a